↓ Skip to main content

Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis

Overview of attention for article published in BMC Medicine, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

policy
1 policy source
twitter
1 tweeter

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
75 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis
Published in
BMC Medicine, June 2010
DOI 10.1186/1741-7015-8-36
Pubmed ID
Authors

Chamila Geeganage, Robert Wilcox, Philip MW Bath

Abstract

Dual antiplatelet therapy is usually superior to mono therapy in preventing recurrent vascular events (VEs). This systematic review assesses the safety and efficacy of triple antiplatelet therapy in comparison with dual therapy in reducing recurrent vascular events.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Hungary 1 1%
Indonesia 1 1%
Australia 1 1%
Brazil 1 1%
India 1 1%
Spain 1 1%
Unknown 69 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 17%
Student > Postgraduate 11 15%
Other 11 15%
Student > Master 7 9%
Student > Ph. D. Student 7 9%
Other 17 23%
Unknown 9 12%
Readers by discipline Count As %
Medicine and Dentistry 46 61%
Nursing and Health Professions 4 5%
Unspecified 3 4%
Agricultural and Biological Sciences 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 4 5%
Unknown 13 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2012.
All research outputs
#1,421,708
of 7,072,903 outputs
Outputs from BMC Medicine
#1,068
of 1,487 outputs
Outputs of similar age
#66,819
of 287,168 outputs
Outputs of similar age from BMC Medicine
#64
of 80 outputs
Altmetric has tracked 7,072,903 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.5. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,168 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.